Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand

Journal of Pharmaceutical and Biomedical Analysis

Volumn 34, Issue 2, 2004, Pages 341-348

  Gomez, Y ^a   Adams, E ^a   Hoogmartens, J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Clopidogrel; Copies; Dissolution; Liquid chromatography

Indexed keywords

CERUVIN 75; CLAVIX; CLODREL; CLOPIDOGREL; CLOPIFRAN; CLOPIGREL; CLOPILET; CLOPLAT 75; CLOPLATIC; DEPLATT; NEFAZAN; NOKLOT; ORAWIS; PLAGREL; PLAGRIL; PREVA; STROMIX; TALCOM;

ARTICLE; DISSOLUTION; DRUG PACKAGING; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; ENANTIOMER; ENANTIOSELECTIVITY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TABLET;

EID: 0842265756     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00533-8     Document Type: Article

References (11)

1. Jarvis B., Simpson K. Drugs. 60:2000;347-377.
2. CAPRIE Steering Committee, Lancet 348 (1996) 1329-1339.
3. Bertand M.E., Rupprecht H.J., Urban P., Gershlick A.H. Circulation. 102:2000;624-629.
4. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. N. Engl. J. Med. 345:2001;494-502.
5. Savi P., Combalbert J., Gaich C., Rouchon M.C., Maffrand J.P., Berger Y., Herbert J.M. Thromb. Haemost. 72:1994;313-317.
6. Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Tripartite Guideline Q3B: Impurities in New Drug Products, 1996.
7. Mitakos A., Panderi I. J. Pharm. Biomed. Anal. 28:2002;431-438.
8. Reist M., Roy-de Vos M., Montseny J.-P., Mayer J.M., Carrupt P.-A., Berger Y., Testa B. Drug Metab. Dispos. 28:2000;1405-1410.
9. Zhang K., Zhang Z., Wang Q., Gao R. CAN. 138:2002;95716.
10. European Pharmacopoeia, fourth ed., European Department for the Quality of Medicines, Strasbourg, France, 2002.
11. United States Pharmacopeia, 24th ed., United States Pharmacopeial Convention, Rockville, MD, 2000.